search
Back to results

Tobacco Treatment Using EMDR (ToTEM) (ToTEM)

Primary Purpose

Tobacco Use Disorder

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR)
TAU only: Community Reinforcement Approach (CRA) + SCP
Sponsored by
IrisZorg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tobacco Use Disorder focused on measuring Addiction, Tobacco, EMDR

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

In order to be eligible to participate in this study, patients must meet the following criteria:

  • Diagnosis of Tobacco Use Disorder according to the DSM-5 (American Psychiatric Association, 2013) criteria.
  • Age ≥ 18 years.
  • Good Dutch language proficiency (based on clinical judgement).
  • Smoking, on average, ≥ 10 cigarettes per day pre-admission.
  • A score of at least 5 on a scale from 0 to 10, for motivation and self-efficacy
  • A planned inpatient stay of ≥ 4 weeks.
  • Written informed consent.

Exclusion Criteria:

A patient who meets any of the following criteria will be excluded from participation in this study:

- Serious therapy interfering behavior or symptoms that also interfere with TAU, based on clinical judgement (e. g. psychiatric or medical crisis that requires immediate intervention).

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Experimental

    Arm Label

    TAU only: Community Reinforcement Approach (CRA) + a regular smoking cessation program

    TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR) + TAU (CRA)

    Arm Description

    TAU only

    TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR)

    Outcomes

    Primary Outcome Measures

    Retention of participants
    The retention of participants from randomization until the last follow-up.
    Acceptability in terms of compliance
    The acceptability of AF-EMDR to participants in terms of compliance, measured by the total number of sessions attended and the proportion of attended versus non attended (planned) sessions; a higher proportion of attended sessions reflects better compliance.
    Acceptability in terms of adherence
    The acceptability of AF-EMDR to therapists in terms of adherence to the protocol, measured by the score of an independent rater on an a-priori established adherence rating protocol; a higher score reflects better adherence.

    Secondary Outcome Measures

    Proportion of participants
    The proportion of patients at the clinic that are potentially eligible and provide informed consent.
    The feasibility of the outcome measures
    The feasibility of the outcome measures in terms of completion of questionnaires (% per questionnaire and total).
    The acceptability of the outcome measures
    The acceptability of the outcome measures in terms of Likert-type ratings by participants, therapists and research assistants.
    Missing data
    Amount of missing data, measured by total number of missing values and the proportion of completed versus missing data.

    Full Information

    First Posted
    October 7, 2022
    Last Updated
    October 21, 2022
    Sponsor
    IrisZorg
    Collaborators
    Radboud University Medical Center
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05594810
    Brief Title
    Tobacco Treatment Using EMDR (ToTEM)
    Acronym
    ToTEM
    Official Title
    The Feasibility and Potential Efficacy of Adding Tobacco Treatment Using EMDR (ToTEM) to a Regular Smoking Cessation Program A Pilot Randomized Controlled Trail in Inpatient Daily Smokers With a Substance Use Disorder
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    January 1, 2023 (Anticipated)
    Primary Completion Date
    March 31, 2024 (Anticipated)
    Study Completion Date
    December 31, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    IrisZorg
    Collaborators
    Radboud University Medical Center

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Rationale: It is well established that tobacco use has severe health consequences. The prevalence of Tobacco Use Disorder (TUD) is among the highest in populations with Substance Use Disorders (SUD). Despite behavioral and pharmacological treatment options, relapse rates remain high. Therefore, there is a need for additional smoking cessation treatment options that aid long-term abstinence. A potential interesting intervention is addiction-focused Eye Movement Desensitization and Reprocessing (AF-EMDR) therapy. However, the limited research on AF-EMDR therapy and mixed findings thus far prohibit clinical use. Recently, on the basis of diverse findings thus far, an adjusted AF-EMDR protocol has been developed.
    Detailed Description
    SUMMARY Rationale: It is well established that tobacco use has severe health consequences. The prevalence of Tobacco Use Disorder (TUD) is among the highest in populations with Substance Use Disorders (SUD). Despite behavioral and pharmacological treatment options, relapse rates remain high. Therefore, there is a need for additional smoking cessation treatment options that aid long-term abstinence. A potential interesting intervention is addiction-focused Eye Movement Desensitization and Reprocessing (AF-EMDR) therapy. However, the limited research on AF-EMDR therapy and mixed findings thus far prohibit clinical use. Recently, on the basis of diverse findings thus far, an adjusted AF-EMDR protocol has been developed. Objective: to investigate areas of uncertainty about a possible future definitive RCT using AF-EMDR as an add-on intervention to a Smoking Cessation Program (SCP), by determining: Feasibility/process outcomes (e.g. recruitment, adherence, treatment fidelity). Preliminary clinical efficacy in order to estimate the effect size for a future power analysis. Study design: a pilot study with a two-armed randomized controlled design is used in which AF-EMDR + Treatment As Usual (TAU) (Community Reinforcement Approach (CRA) aimed at SUD + a SCP) is contrasted with TAU-only with an intervention phase of three weeks pre- and post intervention assessments and a follow-up after one and three months. Study population: daily smoking adults, admitted to an inpatient addiction care clinic. A total of 50 eligible participants will be allocated at random to one of two treatment groups. - In order to be eligible, patients must meet the following criteria: 1) age ≥ 18 years, 2) good Dutch language proficiency, 3) a DSM-5 diagnosis of Tobacco Use Disorder, 4) smoking, on average, ≥ 10 cigarettes per day pre-admission, 5) A score of at least 5 on a scale from 0 to 10, for motivation and self-efficacy, 6) a planned inpatient stay of ≥ 4 weeks, and 7) written informed consent. Respondents who demonstrate serious therapy interfering behavior or symptoms that also interfere with TAU will be excluded from participation in this study (e. g. psychiatric or medical crisis that requires immediate intervention). Intervention: a total of six 45-90 min. sessions of AF-EMDR twice per week added to a SCP embedded in TAU. Main study parameters/endpoints: Feasibility, design, recruitment and protocol issues. Changes in tobacco craving and smoking behavior.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Tobacco Use Disorder
    Keywords
    Addiction, Tobacco, EMDR

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Study design: a pilot study with a two-armed randomized controlled design is used in which AF-EMDR + Treatment As Usual (TAU) (Community Reinforcement Approach (CRA) aimed at SUD + a SCP) is contrasted with TAU-only with an intervention phase of three weeks pre- and post intervention assessments and a follow-up after one and three months.
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    50 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    TAU only: Community Reinforcement Approach (CRA) + a regular smoking cessation program
    Arm Type
    Active Comparator
    Arm Description
    TAU only
    Arm Title
    TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR) + TAU (CRA)
    Arm Type
    Experimental
    Arm Description
    TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR)
    Intervention Type
    Behavioral
    Intervention Name(s)
    TAU + Addiction focussed - eye movement desensitization and reprocessing (AF-EMDR)
    Other Intervention Name(s)
    AF-EMDR
    Intervention Description
    A total of six 45-90 min. sessions of AF-EMDR therapy with an average frequency of twice per week added to a SCP embedded in CRA. AF-EMD therapy consists of a rationale, installating a treatment goal, desensitasing mental video's, installation of positive cognition, future template and positive ending.
    Intervention Type
    Behavioral
    Intervention Name(s)
    TAU only: Community Reinforcement Approach (CRA) + SCP
    Other Intervention Name(s)
    CRA (+SCP)
    Intervention Description
    CRA is a comprehensive cognitive behavioural treatment that focuses on helping people discover and adopt a pleasurable, social and healthy lifestyle that is more rewarding than a lifestyle including substance use. Within CRA a regular smoking cessation program is embedded.
    Primary Outcome Measure Information:
    Title
    Retention of participants
    Description
    The retention of participants from randomization until the last follow-up.
    Time Frame
    1 year
    Title
    Acceptability in terms of compliance
    Description
    The acceptability of AF-EMDR to participants in terms of compliance, measured by the total number of sessions attended and the proportion of attended versus non attended (planned) sessions; a higher proportion of attended sessions reflects better compliance.
    Time Frame
    1 year
    Title
    Acceptability in terms of adherence
    Description
    The acceptability of AF-EMDR to therapists in terms of adherence to the protocol, measured by the score of an independent rater on an a-priori established adherence rating protocol; a higher score reflects better adherence.
    Time Frame
    1 year
    Secondary Outcome Measure Information:
    Title
    Proportion of participants
    Description
    The proportion of patients at the clinic that are potentially eligible and provide informed consent.
    Time Frame
    1 year
    Title
    The feasibility of the outcome measures
    Description
    The feasibility of the outcome measures in terms of completion of questionnaires (% per questionnaire and total).
    Time Frame
    1 year
    Title
    The acceptability of the outcome measures
    Description
    The acceptability of the outcome measures in terms of Likert-type ratings by participants, therapists and research assistants.
    Time Frame
    1 year
    Title
    Missing data
    Description
    Amount of missing data, measured by total number of missing values and the proportion of completed versus missing data.
    Time Frame
    1 year
    Other Pre-specified Outcome Measures:
    Title
    Demographics
    Description
    Demographics, as inventoried by a structured interview and patient files.
    Time Frame
    1 year
    Title
    Smoking history
    Description
    Smoking (cessation history), inventoried by a structured interview and patient files.
    Time Frame
    1 year
    Title
    DSM-5
    Description
    Current DSM-5 diagnoses, inventoried by a structured interview and patient files.
    Time Frame
    1 year
    Title
    Motivation
    Description
    Motivation to quit smoking, measured by a Likert-type scale from 0 to 10; a higher score reflects a higher motivation.
    Time Frame
    1 year
    Title
    Self-efficacy
    Description
    Smoking cessation self-efficacy, measured by a Likert-type scale from 0 to 10; a higher score reflects a higher self-efficacy.
    Time Frame
    1 year
    Title
    Nicotine dependence
    Description
    Severity of nicotine dependence, measured by the Fagerström Test of Nicotine Dependence, providing a score from 0 to 10; a higher score reflects a more severe dependence.
    Time Frame
    1 year
    Title
    Time to relapse
    Description
    Time to relapse (from the end of the AF-EMDR intervention, if abstinence is achieved), measured in number of days from the end of the AF-EMDR intervention until first cigarette smoked. The higher the number of days, the longer the time to relapse.
    Time Frame
    1 year
    Title
    Smoking behavior
    Description
    Changes from baseline (T0) to T1-T2-T3 in: Smoking behavior, measured by mean number of cigarettes smoked per day over the past 7 days; a higher score means a worse outcome.
    Time Frame
    1 year
    Title
    Tobacco craving
    Description
    Changes from baseline (T0) to T1-T2-T3 in: Tobacco craving, as measured by the total score on the Questionnaire of Smoking Urges - Brief version; a higher score means a worse outcome.
    Time Frame
    1 year
    Title
    Craving related self-control/self-efficacy
    Description
    Changes from baseline (T0) to T1-T2-T3 in: Craving related self-control/self-efficacy. As measured by a subscale of the Self-control cognitions Questionnaire; a higher score means a worse outcome.
    Time Frame
    1 year
    Title
    Positive incentive value
    Description
    Changes from baseline (T0) to T1-T2-T3 in: Positive incentive value. As measured by a subscale of the Self-control cognitions Questionnaire; a higher score means a worse outcome.
    Time Frame
    1 year
    Title
    Level of Urge
    Description
    Within AF-EMDR session changes in: Mean Level of Urge, measured by a Likert-type scale from 0 to 10; a higher score means a worse outcome.
    Time Frame
    1 year
    Title
    Level of Positive Affect
    Description
    Within AF-EMDR session changes in: Mean Level of Positive Affect, measured by a Likert-type scale from 0 to 10; a higher score means a worse outcome
    Time Frame
    1 year

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: In order to be eligible to participate in this study, patients must meet the following criteria: Diagnosis of Tobacco Use Disorder according to the DSM-5 (American Psychiatric Association, 2013) criteria. Age ≥ 18 years. Good Dutch language proficiency (based on clinical judgement). Smoking, on average, ≥ 10 cigarettes per day pre-admission. A score of at least 5 on a scale from 0 to 10, for motivation and self-efficacy A planned inpatient stay of ≥ 4 weeks. Written informed consent. Exclusion Criteria: A patient who meets any of the following criteria will be excluded from participation in this study: - Serious therapy interfering behavior or symptoms that also interfere with TAU, based on clinical judgement (e. g. psychiatric or medical crisis that requires immediate intervention).
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Reinier van den Haak, MSc
    Phone
    088 - 606 1152
    Email
    r.haak@iriszorg.nl
    First Name & Middle Initial & Last Name or Official Title & Degree
    Wiebren Markus
    Phone
    088 - 606 1396
    Email
    w.markus@iriszorg.nl

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided
    IPD Sharing Plan Description
    Depending on the final data collection and the journal in which these are published, we will decide on availability of IPD

    Learn more about this trial

    Tobacco Treatment Using EMDR (ToTEM)

    We'll reach out to this number within 24 hrs